1
/
of
1
Elabscience
SKU:PKSQ050074
Recombinant Rhesus macaque ICOS/AILIM/CD278 Protein (Fc Tag)
Recombinant Rhesus macaque ICOS/AILIM/CD278 Protein (Fc Tag)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Rhesus macaque ICOS/AILIM/CD278 Protein (Fc Tag), a cutting-edge product designed to revolutionize the field of immunology research. This meticulously engineered protein, derived from the Rhesus macaque species, offers unparalleled potential for investigating the intricate mechanisms of immune response.
The Recombinant Rhesus macaque ICOS/AILIM/CD278 Protein (Fc Tag) boasts a recombinant fusion construct, meticulously designed to incorporate the Fc tag for enhanced stability and ease of detection. This fusion protein exhibits exceptional purity and bioactivity, ensuring reliable and reproducible results in a wide range of experimental settings.
With its unique Fc tag, this protein enables facile purification and detection, simplifying the workflow and expediting research progress. The fusion construct also facilitates interaction studies, allowing for comprehensive investigations into the intricate interplay between ICOS/AILIM/CD278 and its binding partners.
This recombinant protein is meticulously produced using advanced biotechnological techniques, ensuring high expression levels and consistent quality. Rigorous quality control measures are implemented throughout the manufacturing process to guarantee the utmost purity, functionality, and stability of the final product.
The Recombinant Rhesus macaque ICOS/AILIM/CD278 Protein (Fc Tag) holds immense potential for a myriad of applications, including but not limited to immunology research, drug discovery, and therapeutic development. Its versatility and reliability make it an indispensable tool for scientists and researchers striving to unravel the complexities of immune regulation.
In summary, the Recombinant Rhesus macaque ICOS/AILIM/CD278 Protein (Fc Tag) represents a breakthrough in immunology research, offering a highly pure, bioactive, and stable protein for comprehensive investigations into immune response mechanisms. With its exceptional quality and versatility, this product is poised to revolutionize the field and drive scientific advancements in the quest for improved therapies and treatments.
The Recombinant Rhesus macaque ICOS/AILIM/CD278 Protein (Fc Tag) boasts a recombinant fusion construct, meticulously designed to incorporate the Fc tag for enhanced stability and ease of detection. This fusion protein exhibits exceptional purity and bioactivity, ensuring reliable and reproducible results in a wide range of experimental settings.
With its unique Fc tag, this protein enables facile purification and detection, simplifying the workflow and expediting research progress. The fusion construct also facilitates interaction studies, allowing for comprehensive investigations into the intricate interplay between ICOS/AILIM/CD278 and its binding partners.
This recombinant protein is meticulously produced using advanced biotechnological techniques, ensuring high expression levels and consistent quality. Rigorous quality control measures are implemented throughout the manufacturing process to guarantee the utmost purity, functionality, and stability of the final product.
The Recombinant Rhesus macaque ICOS/AILIM/CD278 Protein (Fc Tag) holds immense potential for a myriad of applications, including but not limited to immunology research, drug discovery, and therapeutic development. Its versatility and reliability make it an indispensable tool for scientists and researchers striving to unravel the complexities of immune regulation.
In summary, the Recombinant Rhesus macaque ICOS/AILIM/CD278 Protein (Fc Tag) represents a breakthrough in immunology research, offering a highly pure, bioactive, and stable protein for comprehensive investigations into immune response mechanisms. With its exceptional quality and versatility, this product is poised to revolutionize the field and drive scientific advancements in the quest for improved therapies and treatments.
Share
